Follow us on...
IconTwitterlinkedin





Search News Archives
Search for a Supplier

Company Name:


Location:

Product:

E-Newsletters
E Newsletter sign up
Calendar of events
«  »
SMTWTFS
 12345
6789101112
13141516171819
20212223242526
2728293031 
Social Media
twitter
Facebook
linkedin

AMSBIO and Chondrex Cooperate On Arthritis & Inflammation Research

publication date: Sep 23, 2011
 | 
author/source: AMS Biotechnology
Download Print Send a summary of this page to someone via email.
amsbioAMSBIO has announced a pan European partnership with Chondrex Inc. to market their high quality arthritis and inflammation reagents to academics and pharmaceutical companies that do research in these fields.

The range includes a suite of high quality reagents such as highly purified cartilage collagen and collagen monoclonal antibodies to provide scientists with the necessary tools to study the pathogenesis as well as to develop and screen potential therapeutics for Rheumatoid Arthritis (RA). In addition, AMSBIO has also improved its capability to provide reagents and various assay kits for the investigation of other important inflammatory diseases such as nephritis and allergic asthma.

Multi species Collagen reactive antibodies are available that can be used in western blotting, immunostaining and for inducing Collagen Antibody-Induced Arthritis (CAIA).

Collagenases, members of the matrix metalloproteinase (MMP) family, are involved in the physiological and pathological turnover of connective tissues. Collagenase production is significantly increased at the sites of inflammation due to the stimulation of pro-inflammatory cytokines. AMSBIO is now able to provide recombinant human MMP-8 and MMP-13, in addition to collagenase assay kits using FITC-labeled type I collagen and type II collagen, or a fluorogenic peptide as substrates. The new AMSBIO arthritis & inflammation research reagent range also includes type I and type II collagen specially purified for antibody assay by ELISA.

For a catalogue detailing this exciting new range of high quality reagents for arthritis & inflammation research please visit http://www.amsbio.com/partners_chondrex.aspx or contact AMSBIO on +44-1235-828200 / +1-949-768-8365 or email info@amsbio.com

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized as a leading international provider of unique innovative products & custom services for life sciences research. The AMSBIO range includes over 23,000 polyclonal & monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, & tissue DNA, RNA, protein & microarray products. Key research areas include: apoptosis, cell invasion & migration, cell signaling, DNA damage, 3D culture, electrophoresis, glycobiology, post-translational modification & stem cell biology.



blog comments powered by Disqus



Can't find what you are looking for?

Company Name:

Location:

Product:



Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have a product enquiry, please contact the supplier directly.


Lab Bulletin is published by newleaf marketing communications ltd
Lab Bulletin 2012 Media information Pack